[
  {
    "ts": null,
    "headline": "ENA Foundation Honors Three with Keystone Award",
    "summary": "As part of ENA's annual awards season, the ENA Foundation announced three recipients of the Keystone Award: longtime donor and ENA member Jackie Taylor-Wynkoop; the New Jersey ENA State Council; and corporate partner Stryker.",
    "url": "https://finnhub.io/api/news?id=d89b37b63fbb24ba1fc9400b7a1e8cc186134bbc8131217aec3b17bf4dade28f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755114600,
      "headline": "ENA Foundation Honors Three with Keystone Award",
      "id": 136339766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "As part of ENA's annual awards season, the ENA Foundation announced three recipients of the Keystone Award: longtime donor and ENA member Jackie Taylor-Wynkoop; the New Jersey ENA State Council; and corporate partner Stryker.",
      "url": "https://finnhub.io/api/news?id=d89b37b63fbb24ba1fc9400b7a1e8cc186134bbc8131217aec3b17bf4dade28f"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?",
    "summary": "Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.",
    "url": "https://finnhub.io/api/news?id=e63a708f98096666c4abc908f96795267db0f4602b5d516bcab511f5f8fe4d01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755089460,
      "headline": "ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?",
      "id": 136339687,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.",
      "url": "https://finnhub.io/api/news?id=e63a708f98096666c4abc908f96795267db0f4602b5d516bcab511f5f8fe4d01"
    }
  },
  {
    "ts": null,
    "headline": "Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions",
    "summary": "The Orthopedic Devices Companies Quadrant provides in-depth analysis of the global orthopedic devices market, spotlighting key players and industry trends. According to MarketsandMarkets 360 Quadrants, the top 14 orthopedic device companies have been identified as quadrant leaders. Driven by an aging population and rising orthopedic conditions, this market is growing steadily. Key innovations like orthobiologics, robotic surgeries, and 3D printing are creating new opportunities. Major companies",
    "url": "https://finnhub.io/api/news?id=3ec85e96e200ecbbba3dbd179310c7b5c19397795361430c5b5ae7355d889b53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755080820,
      "headline": "Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions",
      "id": 136328430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "The Orthopedic Devices Companies Quadrant provides in-depth analysis of the global orthopedic devices market, spotlighting key players and industry trends. According to MarketsandMarkets 360 Quadrants, the top 14 orthopedic device companies have been identified as quadrant leaders. Driven by an aging population and rising orthopedic conditions, this market is growing steadily. Key innovations like orthobiologics, robotic surgeries, and 3D printing are creating new opportunities. Major companies",
      "url": "https://finnhub.io/api/news?id=3ec85e96e200ecbbba3dbd179310c7b5c19397795361430c5b5ae7355d889b53"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
    "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
    "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755072900,
      "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
      "id": 136327951,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
      "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b"
    }
  },
  {
    "ts": null,
    "headline": "SYK Q2 Deep Dive: Tariffs, Supply Chain, and Robotics Weigh on Market Sentiment",
    "summary": "Medical technology company Stryker (NYSE:SYK) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 11.1% year on year to $6.02 billion. Its non-GAAP profit of $3.13 per share was 1.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=173c6c9b965db09fd94fd71f6eed744fb0c179b63f1c476a524046d95c554161",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755057057,
      "headline": "SYK Q2 Deep Dive: Tariffs, Supply Chain, and Robotics Weigh on Market Sentiment",
      "id": 136328431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Medical technology company Stryker (NYSE:SYK) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 11.1% year on year to $6.02 billion. Its non-GAAP profit of $3.13 per share was 1.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=173c6c9b965db09fd94fd71f6eed744fb0c179b63f1c476a524046d95c554161"
    }
  },
  {
    "ts": null,
    "headline": "5 Revealing Analyst Questions From Stryker’s Q2 Earnings Call",
    "summary": "Stryker’s second quarter results were met with a negative market reaction, despite the company surpassing Wall Street’s revenue and profit expectations. Management described robust demand across its core product portfolio, particularly highlighting double-digit growth in MedSurg and Neurotechnology and solid performance in orthopedics. CEO Kevin Lobo pointed to strong U.S. momentum, driven by procedural volume growth, expanding adoption of robotic-assisted surgery, and healthy hospital capital s",
    "url": "https://finnhub.io/api/news?id=09e3c28f6b60ba0952868f85bd84dc5933f2bfdb4ffaaa7e45890486eb85e7c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755056391,
      "headline": "5 Revealing Analyst Questions From Stryker’s Q2 Earnings Call",
      "id": 136328432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker’s second quarter results were met with a negative market reaction, despite the company surpassing Wall Street’s revenue and profit expectations. Management described robust demand across its core product portfolio, particularly highlighting double-digit growth in MedSurg and Neurotechnology and solid performance in orthopedics. CEO Kevin Lobo pointed to strong U.S. momentum, driven by procedural volume growth, expanding adoption of robotic-assisted surgery, and healthy hospital capital s",
      "url": "https://finnhub.io/api/news?id=09e3c28f6b60ba0952868f85bd84dc5933f2bfdb4ffaaa7e45890486eb85e7c1"
    }
  }
]